The global medical technology company BD launched the BD Institute of Medication Management Excellence to bolster medication safety across the care continuum.
The institute will provide a collaborative setting for customers and industry thought leaders to participate in research toward the development of advancements in medication management to improve patient safety and reduce costs.
The institute will initially focus on three key initiatives:
• Intravenous line safety
• Medication availability
• Managing and controlling opioids
"To make the next level of advancement in medication management, we need to take a systems view and in the process, better connect technology in a way that will simplify the work and make it easier to do the right thing," said David Bates, MD, chief of general internal medicine at Brigham and Women's Hospital in Boston. "BD has the ideal platform and expertise to help advance and innovate across the discipline of medication management."
More articles on quality:
Diabetes more deadly than previously thought, researchers say
AORN patient positioning guideline open for comment
Large genetic study identifies 14 new developmental disorders